查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601247

熱原測試市場：按產品類型、測試類型、最終用戶分類 - 全球預測 2025-2030

Pyrogen Testing Market by Product Type (Assays, Kits, & Reagents, Instruments, Services), Test Type (Limulus Amoebocyte Lysate, Monocyte Activation Test, Rabbit Pyrogen Test), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年熱原測試市場價值為12.4億美元，預計到2024年將達到13.8億美元，複合年成長率為11.64%，到2030年將達到26.8億美元。

熱原測試是製藥和醫療設備產業的重要過程，以確保產品不含可能引起人類發燒或不良免疫反應的污染物。熱原測試的需求源於嚴格的監管要求，以保護患者安全並確保產品功效，這對注射藥物、疫苗和醫療設備等多種領域的應用做出了重大貢獻。最終用途產業主要是製藥、生技和醫療設備公司。影響熱原檢測市場的主要發展因素包括藥物研發活動的增加、需要創新藥物開拓的慢性疾病的快速增加以及生物製藥公司的建立不斷增加。此外，生物技術的進步為替代測試方法鋪平了道路，例如單核細胞活化測試（MAT）等體外測試，其在倫理和技術上都優於傳統的動物測試，這提供了潛在的商機。向生物製藥和生物相似藥的日益轉變增加了對高效解決方案的需求，預計市場前景將進一步擴大。然而，這個市場面臨一些限制，例如與複雜的測試方法相關的高成本以及經常延遲產品核可的複雜的法律規範。同樣具有挑戰性的是開發能夠準確模擬體內條件的測試的技術複雜性。儘管存在這些障礙，創新領域包括開發更具成本效益、更快、更準確的體外測試方法，以及使用人工智慧和機器學習來簡化流程等。熱原測試市場的本質是競爭性的，重點是技術進步和收購，以擴大產品系列併提高市場佔有率。尋求發展的公司可以透過策略聯盟瞄準這些領域，投資新解決方案的研發，並確保遵守不斷變化的監管標準，從而最大限度地降低風險並最大限度地佔領市場。

主要市場統計
基準年[2023] 12.4億美元
預測年份 [2024] 13.8億美元
預測年份 [2030] 26.8億美元
複合年成長率（%） 11.64%

市場動態：揭示快速發展的熱原測試市場的關鍵市場洞察

供需的動態交互作用正在改變熱原測試市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球感染疾病和慢性病盛行率上升
    • 增加藥品、生技藥品和醫療設備產品的產量
    • 全球衛生當局的嚴格法規和標準
  • 市場限制因素
    • 與先進的熱原測試方法相關的高成本
  • 市場機會
    • 熱原測試技術的技術進步
    • 供應商和製藥公司合作擴大熱原測試方法的部署
  • 市場挑戰
    • 與熱原測試相關的操作和道德問題

波特五力：駕馭熱原測試市場的策略工具

波特的五力框架是了解熱原測試市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對熱原測試市場的影響

外部宏觀環境因素在塑造熱原測試市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解熱原測試市場的競爭狀況

對熱原測試市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣熱原測試市場供應商的績效評估

FPNV定位矩陣是評估熱原測試市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃熱原測試市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，熱原測試市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地感染疾病和慢性病的發生率正在上升
      • 增加藥品、生技藥品和醫療設備產品的產量
      • 世界各地衛生當局製定的嚴格法規和標準
    • 抑制因素
      • 與先進的熱原測試方法相關的高成本
    • 機會
      • 熱原測試技術的技術進步
      • 市場供應商和製藥公司之間的合作擴大了熱原測試方法的採用
    • 任務
      • 與熱原測試相關的操作和道德問題
  • 市場區隔分析
    • 產品類型：對自動化、加速和增強測試過程的檢測、套件和試劑的需求增加
    • 測試類型：由於高靈敏度和可靠性，鱟試劑測試的使用正在增加。
    • 最終用戶：生技公司的熱原測試採用率激增
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章熱原測試市場：依產品類型

  • 測定、套件和試劑
  • 裝置
  • 服務

第7章按測試類型分類的熱原測試市場

  • 鱟阿米巴細胞裂解物
    • 顯色試驗
    • 凝膠血液凝固檢驗
    • 濁度測量測試
  • 單核細胞活化試驗
  • 兔熱原試驗
  • 重組連鎖試劑
  • 重組因子C

第8章熱原測試市場：依最終用戶分類

  • 生技公司
  • 醫療設備公司
  • 製藥公司

第9章 北美和南美熱原測試市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太熱原測試市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲熱原檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • FUJIFILM與 Predictive Oncology 合作改進細菌內毒素檢測
    • 使用重組 C 因子檢測製藥用水細菌內毒素的新彈性
    • Charles River Laboratories 推出 Endsafe Trillium rCR 試劑盒，用於高效、非動物測試
    • Lonza 推出先進的快速 MAT 系統
    • Wickham Micro 擴大細菌內毒素檢測設施，以滿足醫療和製藥行業不斷成長的需求
    • MiCAN Technologies 籌集了 2 億美元，利用創新的 MylcMAT 產品推動非動物熱原測試
    • Lonza 推出了星雲分光光度計，用於其品管實驗室的熱原和內毒素檢測。
    • 新的 ISO 標準 ISO 11737-3:2023 強化了醫療產品細菌內毒素檢測指南
  • 戰略分析和建議
    • 諾和諾德公司
    • FUJIFILM Holdings控股有限公司
    • 沃特斯公司
    • 默克
    • 查爾斯河實驗室國際有限公司

公司名單

  • Accugen Laboratories, Inc.
  • Almac Group
  • Associates of Cape Cod, Inc.
  • bioMerieux SA
  • Charles River Laboratories International, Inc.
  • Corning Incorporated
  • Creative Bioarray
  • Eurofins Scientific SE
  • FUJIFILM Holdings Corporation
  • Genscript Biotech Corporation
  • Hycult Biotechnology BV
  • IDEXX Laboratories, Inc.
  • Incell Corporation LLC
  • Indoor Biotechnologies, Inc.
  • InvivoGen SAS
  • Laboratory Corporation of America Holdings
  • Lonza Group AG
  • Lucideon Limited
  • MAT BioTech BV
  • Merck KGaA
  • Microcoat Biotechnologie GmbH
  • Minerva Biolabs GmbH
  • Nelson Laboratories, LLC by Sotera Health Company
  • North American Science Associates, LLC
  • Novo Nordisk A/S
  • Pacific Biolabs Inc.
  • QIAGEN NV
  • Solvias AG
  • Steris PLC
  • Thermo Fisher Scientific Inc.
  • Veolia Environnement SA
  • Waters Corporation
  • Wickham Micro Limited by Cormica Group
  • WuXi AppTec Co., Ltd.
Product Code: MRR-035AB9C0DA61

The Pyrogen Testing Market was valued at USD 1.24 billion in 2023, expected to reach USD 1.38 billion in 2024, and is projected to grow at a CAGR of 11.64%, to USD 2.68 billion by 2030.

Pyrogen testing is a critical process in the pharmaceutical and medical devices industries, ensuring that products are free from contaminants that can cause fever and adverse immunological responses in humans. The necessity for pyrogen testing arises from stringent regulatory mandates to safeguard patient safety and ensure product efficacy, contributing significantly to its application across diverse segments such as injectable drugs, vaccines, and medical devices. End-use industries predominantly include pharmaceuticals, biotechnology, and medical devices companies. Key growth factors influencing the pyrogen testing market include increasing pharmaceutical R&D activities, surging prevalence of chronic diseases necessitating innovative drug development, and the rise in biopharmaceutical firm establishment. Moreover, advancements in biotechnology have opened avenues for alternative testing methods, such as in vitro tests like the Monocyte Activation Test (MAT), which present potential opportunities owing to their ethical and technical advantages over traditional animal-based tests. The ongoing shift toward biologicals and biosimilars creates an extra demand for efficacious pyrogen testing solutions, offering further market prospects. However, the market faces limitations like high costs associated with advanced testing methods and complex regulatory frameworks that often delay product approvals. Challenges also include technical intricacies in developing tests that can accurately simulate in vivo conditions. Despite these hurdles, areas ripe for innovation include developing more cost-effective, faster, and precise in vitro testing methods, as well as harnessing AI and machine learning to streamline detection and analysis processes. The nature of the pyrogen testing market is competitive, with significant focus on technological advancements and acquisitions to broaden product portfolios and enhance market presence. Companies seeking growth can target these areas through strategic collaborations, investing in R&D for novel solutions, and ensuring compliance with evolving regulatory standards to minimize risks and maximize market capture.

KEY MARKET STATISTICS
Base Year [2023] USD 1.24 billion
Estimated Year [2024] USD 1.38 billion
Forecast Year [2030] USD 2.68 billion
CAGR (%) 11.64%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pyrogen Testing Market

The Pyrogen Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of infectious and chronic diseases worldwide
    • Increasing production of pharmaceuticals, biologics, and medical device products
    • Stringent regulations and standards set by health authorities worldwide
  • Market Restraints
    • High cost associated with the advanced pyrogen testing methods
  • Market Opportunities
    • Technological advancements in pyrogen testing technologies
    • Collaboration between market vendors and pharma companies to expand the deployment of pyrogen testing methods
  • Market Challenges
    • Operational and ethical concerns associated with pyrogen testing

Porter's Five Forces: A Strategic Tool for Navigating the Pyrogen Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pyrogen Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pyrogen Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pyrogen Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pyrogen Testing Market

A detailed market share analysis in the Pyrogen Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pyrogen Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pyrogen Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pyrogen Testing Market

A strategic analysis of the Pyrogen Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pyrogen Testing Market, highlighting leading vendors and their innovative profiles. These include Accugen Laboratories, Inc., Almac Group, Associates of Cape Cod, Inc., bioMerieux SA, Charles River Laboratories International, Inc., Corning Incorporated, Creative Bioarray, Eurofins Scientific SE, FUJIFILM Holdings Corporation, Genscript Biotech Corporation, Hycult Biotechnology B.V., IDEXX Laboratories, Inc., Incell Corporation LLC, Indoor Biotechnologies, Inc., InvivoGen S.A.S., Laboratory Corporation of America Holdings, Lonza Group AG, Lucideon Limited, MAT BioTech B.V., Merck KGaA, Microcoat Biotechnologie GmbH, Minerva Biolabs GmbH, Nelson Laboratories, LLC by Sotera Health Company, North American Science Associates, LLC, Novo Nordisk A/S, Pacific Biolabs Inc., QIAGEN N.V., Solvias AG, Steris PLC, Thermo Fisher Scientific Inc., Veolia Environnement S.A., Waters Corporation, Wickham Micro Limited by Cormica Group, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Pyrogen Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Assays, Kits, & Reagents, Instruments, and Services.
  • Based on Test Type, market is studied across Limulus Amoebocyte Lysate, Monocyte Activation Test, Rabbit Pyrogen Test, Recombinant Cascade Reagent, and Recombinant Factor C. The Limulus Amoebocyte Lysate is further studied across Chromogenic Tests, Gel Clot Tests, and Turbidimetric Tests.
  • Based on End-User, market is studied across Biotechnology Companies, Medical Device Companies, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of infectious and chronic diseases worldwide
      • 5.1.1.2. Increasing production of pharmaceuticals, biologics, and medical device products
      • 5.1.1.3. Stringent regulations and standards set by health authorities worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the advanced pyrogen testing methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in pyrogen testing technologies
      • 5.1.3.2. Collaboration between market vendors and pharma companies to expand the deployment of pyrogen testing methods
    • 5.1.4. Challenges
      • 5.1.4.1. Operational and ethical concerns associated with pyrogen testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Increasing need of assays, kits, & reagents to automate, facilitate, or enhance the testing processes
    • 5.2.2. Test Type: Rising usage of the LAL test due to its high sensitivity and reliability
    • 5.2.3. End-User: Burgeoning adoption of pyrogen testing across biotechnology companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pyrogen Testing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Assays, Kits, & Reagents
  • 6.3. Instruments
  • 6.4. Services

7. Pyrogen Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Limulus Amoebocyte Lysate
    • 7.2.1. Chromogenic Tests
    • 7.2.2. Gel Clot Tests
    • 7.2.3. Turbidimetric Tests
  • 7.3. Monocyte Activation Test
  • 7.4. Rabbit Pyrogen Test
  • 7.5. Recombinant Cascade Reagent
  • 7.6. Recombinant Factor C

8. Pyrogen Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Biotechnology Companies
  • 8.3. Medical Device Companies
  • 8.4. Pharmaceutical Companies

9. Americas Pyrogen Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pyrogen Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pyrogen Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. FUJIFILM and Predictive Oncology Partner to Improve Bacterial Endotoxin Testing
    • 12.3.2. New Flexibility for Bacterial Endotoxin Testing in Pharmaceutical Waters with Recombinant Factor C
    • 12.3.3. Charles River Laboratories Launches Endosafe Trillium rCR Cartridge for Efficient, Animal-Free Testing
    • 12.3.4. Lonza Introduces Advanced Rapid MAT Systems
    • 12.3.5. Wickham Micro Expands Bacterial Endotoxin Testing Facilities to Meet Rising Demand in Medical and Pharmaceutical Sectors
    • 12.3.6. MiCAN Technologies Raises JPY 200 Million to Advance Animal-Free Pyrogen Testing with Innovative MylcMAT Product
    • 12.3.7. Lonza Introduced the Nebula Absorbance Reader for Pyrogen and Endotoxin Testing in Quality Control Labs
    • 12.3.8. New ISO Standard ISO 11737-3:2023 Enhances Guidelines for Bacterial Endotoxin Testing in Medical Products
  • 12.4. Strategy Analysis & Recommendation
    • 12.4.1. Novo Nordisk A/S
    • 12.4.2. FUJIFILM Holdings Corporation
    • 12.4.3. Waters Corporation
    • 12.4.4. Merck KGaA
    • 12.4.5. Charles River Laboratories International, Inc.

Companies Mentioned

  • 1. Accugen Laboratories, Inc.
  • 2. Almac Group
  • 3. Associates of Cape Cod, Inc.
  • 4. bioMerieux SA
  • 5. Charles River Laboratories International, Inc.
  • 6. Corning Incorporated
  • 7. Creative Bioarray
  • 8. Eurofins Scientific SE
  • 9. FUJIFILM Holdings Corporation
  • 10. Genscript Biotech Corporation
  • 11. Hycult Biotechnology B.V.
  • 12. IDEXX Laboratories, Inc.
  • 13. Incell Corporation LLC
  • 14. Indoor Biotechnologies, Inc.
  • 15. InvivoGen S.A.S.
  • 16. Laboratory Corporation of America Holdings
  • 17. Lonza Group AG
  • 18. Lucideon Limited
  • 19. MAT BioTech B.V.
  • 20. Merck KGaA
  • 21. Microcoat Biotechnologie GmbH
  • 22. Minerva Biolabs GmbH
  • 23. Nelson Laboratories, LLC by Sotera Health Company
  • 24. North American Science Associates, LLC
  • 25. Novo Nordisk A/S
  • 26. Pacific Biolabs Inc.
  • 27. QIAGEN N.V.
  • 28. Solvias AG
  • 29. Steris PLC
  • 30. Thermo Fisher Scientific Inc.
  • 31. Veolia Environnement S.A.
  • 32. Waters Corporation
  • 33. Wickham Micro Limited by Cormica Group
  • 34. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. PYROGEN TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. PYROGEN TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PYROGEN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PYROGEN TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PYROGEN TESTING MARKET SIZE, BY RABBIT PYROGEN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT CASCADE REAGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PYROGEN TESTING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2023